94 related articles for article (PubMed ID: 31791579)
1. Domain structures of mucosa-associated lymphoid tissue lymphoma translocation 1 protein for nuclear localization in oral carcinoma cells and the proliferation inhibition.
Hayashi H; Chiba T; Mihara-Tomiyama N; Negishi T; Kodama Y; Sakashita H; Imai K
Biochem Biophys Res Commun; 2020 Feb; 522(3):799-804. PubMed ID: 31791579
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGF-β and EGF pathway gene expression and migration of oral carcinoma cells by mucosa-associated lymphoid tissue 1.
Ohyama Y; Kawamoto Y; Chiba T; Maeda G; Sakashita H; Imai K
Br J Cancer; 2013 Jul; 109(1):207-14. PubMed ID: 23778523
[TBL] [Abstract][Full Text] [Related]
3. MALT1 Inhibition of Oral Carcinoma Cell Invasion and ERK/MAPK Activation.
Chiba T; Soeno Y; Shirako Y; Sudo H; Yagishita H; Taya Y; Kawashiri S; Okada Y; Imai K
J Dent Res; 2016 Apr; 95(4):446-52. PubMed ID: 26701346
[TBL] [Abstract][Full Text] [Related]
4. NF-κB subunit RELA suppression of mucosa-associated lymphoid tissue lymphoma translocation protein 1 expression in oral carcinoma cells.
Nozawa T; Mihara-Tomiyama N; Chiba T; Imai K
Biochem Biophys Res Commun; 2021 Jan; 542():24-28. PubMed ID: 33482470
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic loss of mucosa-associated lymphoid tissue 1 expression in patients with oral carcinomas.
Chiba T; Maeda G; Kawashiri S; Kato K; Imai K
Cancer Res; 2009 Sep; 69(18):7216-23. PubMed ID: 19738055
[TBL] [Abstract][Full Text] [Related]
6. Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes.
Wiegmann H; Reunert J; Metze D; Marquardt T; Engel T; Kunde V; Ehl S; Foell D; van den Heuvel I; Oji V; Wittkowski H
Br J Dermatol; 2020 Jan; 182(1):202-207. PubMed ID: 31049936
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of keratin alterations with enhanced proliferation of oral carcinoma cells by loss of mucosa-associated lymphoid tissue 1 expression.
Kawamoto Y; Ohyama Y; Chiba T; Yagishita H; Sakashita H; Imai K
Int J Oncol; 2013 Sep; 43(3):729-36. PubMed ID: 23799590
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms of mucosa-associated lymphoid tissue 1 in oral carcinoma cells and gingival fibroblasts.
Oyama G; Midorikawa T; Matsumoto Y; Takeyama M; Yamada K; Nozawa T; Morikawa M; Imai K
Odontology; 2013 Jul; 101(2):150-5. PubMed ID: 22752732
[TBL] [Abstract][Full Text] [Related]
9. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
[TBL] [Abstract][Full Text] [Related]
10. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
11. Nuclear multicatalytic proteinase subunit RRC3 is important for growth regulation in hepatocytes.
Benedict CM; Clawson GA
Biochemistry; 1996 Sep; 35(36):11612-21. PubMed ID: 8794741
[TBL] [Abstract][Full Text] [Related]
12. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.
Fontán L; Qiao Q; Hatcher JM; Casalena G; Us I; Teater M; Durant M; Du G; Xia M; Bilchuk N; Chennamadhavuni S; Palladino G; Inghirami G; Philippar U; Wu H; Scott DA; Gray NS; Melnick A
J Clin Invest; 2018 Oct; 128(10):4397-4412. PubMed ID: 30024860
[TBL] [Abstract][Full Text] [Related]
13. Development of new Malt1 inhibitors and probes.
Xin BT; Schimmack G; Du Y; Florea BI; van der Marel GA; Driessen C; Krappmann D; Overkleeft HS
Bioorg Med Chem; 2016 Aug; 24(15):3312-29. PubMed ID: 27085674
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells.
Zhu L; Tang F; Lei Z; Guo C; Song Y; Huang J; Xia X
Mol Carcinog; 2019 Dec; 58(12):2340-2352. PubMed ID: 31556968
[TBL] [Abstract][Full Text] [Related]
15. MALT1 is an intrinsic regulator of regulatory T cells.
Brüstle A; Brenner D; Knobbe-Thomsen CB; Cox M; Lang PA; Lang KS; Mak TW
Cell Death Differ; 2017 Jul; 24(7):1214-1223. PubMed ID: 26405015
[TBL] [Abstract][Full Text] [Related]
16. Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain.
Schairer R; Hall G; Zhang M; Cowan R; Baravalle R; Muskett FW; Coombs PJ; Mpamhanga C; Hale LR; Saxty B; Iwaszkiewicz J; Décaillet C; Perroud M; Carr MD; Thome M
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3093-3102. PubMed ID: 31980531
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture and regulation of BCL10-MALT1 filaments.
Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
[TBL] [Abstract][Full Text] [Related]
18. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
[TBL] [Abstract][Full Text] [Related]
19. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
[TBL] [Abstract][Full Text] [Related]
20. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
